Drug Development Considerations for Empiric Antibacterial Therapy in Febrile Neutropenic Patients – 04/23/2024

The purpose of the public workshop is to discuss clinical trial design and other considerations related to the development of antibacterial drug products for treatment of febrile neutropenia (FN).